- Side Effects
What is extracorporeal photopheresis?
Extracorporeal photopheresis (ECP) is a therapeutic procedure for advanced cutaneous T-cell lymphoma (CTCL), which is an immune system cancer that affects the skin. Extracorporeal photopheresis is also known as extracorporeal photochemotherapy and extracorporeal photoimmunotherapy. It may be used as adjunctive therapy in other medical problems.
Extracorporeal photopheresis procedure processes the patient’s blood to selectively treat the white cells and curb their proliferation. Extracorporeal means the entire procedure takes place outside the body. The patient’s blood passes through a device which performs photopheresis (exposure to a photosensitizing substance and then to specific light wavelengths) and returns the treated white cells and blood back into circulation.
How is extracorporeal photopheresis performed?
Extracorporeal photopheresis is performed in specialized laboratories by trained technicians. More than 200 centers worldwide are equipped to perform ECP.
The technician attaches an intravenous (IV) line to a vein in the patient’s arm or the central vein in the upper chest, neck or groin. The IV line is attached to the ECP device, and the blood flows into the device through the IV line.
The ECP device accomplishes photopheresis in three steps:
- Leukapheresis: A combination of white blood cells and platelets (buffy coat) is separated from the blood with the use of centrifugal force. The red blood cells and plasma flow out of the device and back into the patient’s vein through the IV line. This process repeats several times depending on the patient’s weight and hematocrit level, to extract about 5% to 10% of the patient’s white blood cells.
- Photoactivation: The collected buffy coat is mixed with heparin and saline to prevent clotting. A photosensitizing substance, 8-methoxypsoralen (8-MOP) is added to the combination, which then undergoes ultraviolet A (UVA) radiation. The UVA radiation enables the 8-MOP to insert itself into the white cell’s DNA.
- Reinfusion: The photoactivated white cells are reinfused into the patient through the IV line.
Extracorporeal photopheresis may be of two kinds:
- Closed ECP system: In the closed ECP system, the entire process is automated and performed by a single device. The risks of infection and improper reinfusion are minimized.
- Open ECP system: In the open ECP system, leukapheresis and photoactivation are performed in two different devices.
What are the FDA-approved ECP systems?
Only closed ECP systems have FDA approval for the treatment of cutaneous T-cell lymphoma. The following two generations of ECP systems developed by Therakos are approved by FDA:
- UVAR XTS: Second-generation system which collects the buffy coat intermittently.
- Cellex: Third-generation system which collects the buffy coat continuously.
Extracorporeal photopheresis may take from one and a half to four hours depending on the generation of ECP system used. Cellex takes less time and requires lower volume of blood.
How does extracorporeal photopheresis work?
Photopheresis makes the white cells susceptible to apoptosis. Apoptosis is programmed cell death that occurs naturally as a biological process in the body. When apoptosis fails to happen for some reason, cells keep multiplying, which results in cancer.
Researchers are still studying the therapeutic benefits of photopheresis. The apoptosis of treated white cells may also induce apoptosis of other abnormal T-cells. The activated cells appear to also promote immune tolerance and rebalance the immune system, though this effect requires further research.
Latest Cancer News
Daily Health News
What are the conditions extracorporeal photopheresis is used for?
Cutaneous T-cell lymphoma
Cutaneous T-cell lymphoma (CTCL) is a group of T-cell cancers that cause rashes, lesions and tumors in the skin, and can progress to internal organs and lymph nodes. CTCL is the only FDA-approved condition for use of extracorporeal photopheresis. The two most common types of CTCL are
- Mycosis fungoides
- Sezary syndrome
Graft versus host disease (GVHD)
Graft versus host disease is a condition that may occur after a stem cell or bone marrow transplant. The new immune cells produced after the transplant have the donor’s DNA, and attack the patient’s own healthy tissues, considering them foreign.
Autoimmune skin disorders
Autoimmune skin disorders for which extracorporeal photopheresis can be beneficial include:
- Systemic sclerosis/scleroderma
- Severe atopic dermatitis
- Epidermolysis bullosa acquisita
- Erosive oral lichen planus
- Recalcitrant pemphigus vulgaris
- Recalcitrant pemphigus foliaceous
- Rheumatoid arthritis
- Lupus erythematosus
- Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy
Extracorporeal photopheresis can be used as an adjunct treatment for transplant rejection in patients with solid organ transplant. Studies indicate that ECP reduces the donor-specific antibodies in the transplant patient. ECP is found to be beneficial for the following conditions:
Who cannot have extracorporeal photopheresis?
Extracorporeal photopheresis cannot be performed on people with conditions such as:
What are the side effects of extracorporeal photopheresis?
Extracorporeal photopheresis is generally a safe procedure and side effects are mild and temporary. Patients are advised to avoid sun exposure for 24 hours after the procedure.
Potential side effects include:
Health Solutions From Our Sponsors
Top Conditions Extracorporeal Photopheresis lymphoma Related Articles
Burkitt LymphomaBurkitt lymphomas are types of non-Hodgkin's lymphoma that affect the bone marrow and central nervous system. There are multiple types of Burkitt lymphoma. Gene mutations, malaria, and Epstein-Barr virus (EBV) may increase the risk of these cancers. Symptoms of Burkitt lymphoma may include nausea, vomiting, headache, fatigue, enlarged lymph nodes, and many other symptoms. Diagnosis involves lab testing, imaging studies, patient history, and cytogenic evaluation. There are multiple staging systems used to stage Burkitt lymphoma. Treatment consists of chemotherapy. The prognosis of the cancer tends to be more favorable in children than in adults.
Cancer 101 SlideshowLearn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read about the common type of cancers.
Cancer QuizTake this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most common cancers.
Hodgkin's and Non-Hodgkin's Lymphoma: Differences and SimilaritiesBoth Hodgkin's disease (sometimes referred to as Hodgkin's lymphoma) and non-Hodgkin's lymphoma are cancers that originate in a type of white blood cell known as a lymphocyte, an important component of the body's immune system.
How Bad Is Lymphoma Cancer Of Bone?Lymphoma is a cancer of infection-fighting cells (lymphocytes), white blood cells of the immune system. These cells are normally found in the lymph nodes, spleen, thymus, and bone marrow.
How Do You Get Non-Hodgkin’s Lymphoma?Non-Hodgkin lymphoma (NHL) is cancer that affects the lymphatic system, a part of the body’s immune system. The lymphatic system helps in filtering foreign cells and microorganisms. The lymphatic system is comprised of lymph fluid, lymph nodes, tonsils, thymus, and the spleen.
Mantle Cell Lymphoma (MCL)Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin's lymphoma. It is not known what causes MCL. MCL signs and symptoms include fever, enlarged spleen and liver, fatigue, and weight loss. Treatment of MCL incorporates radiotherapy and chemotherapy. MCL has a poor prognosis as it typically is diagnosed in a late stage.
Men's Cancer SymptomsSee pictures of which 15 cancer symptoms men ignore such as skin changes, difficulty swallowing, rapid weight loss, a breast mass, and more. Learn possible clues to finding and detecting cancer early.
Non-Hodgkin's LymphomaNon-Hodgkin's lymphoma is cancer of the lymphatic system, a vital part of the body's immune system. Symptoms and signs include swollen lymph nodes, fever, night sweats, coughing, weakness, chest pain, unexplained weight loss, and abdominal pain. Treatment depends on which type of non-Hodgkin's lymphoma one has, the stage of the cancer, one's age, how fast the cancer is growing, and whether one has other health problems.
Skin Cancer PictureExcessive exposure to sunlight is the main cause of skin cancer. See a picture of Skin Cancer and learn more about the health topic.
Skin Cancer SlideshowDiscover the causes, types, and treatments of skin cancer. Learn how to prevent skin cancer and how to check for melanoma, basal cell carcinoma, and squamous cell carcinoma. Also, find out how to spot the early signs of skin cancer.
What Is the Main Cause of Primary Lymphoma of Bone?Primary lymphoma of bone (PLB) is a rare type of cancer that starts in the bone instead of the lymph nodes. PLB accounts for less than 5% of all bone tumors. PLB is also known as reticulum cell sarcoma, malignant lymphoma of bone or osteolymphoma, and it is a type of non-Hodgkin’s lymphoma. Pain is the most common symptom of PLB.
Female Cancer SymptomsCancer symptoms can surprise women if they don't know what to watch out for. 15 cancer symptoms women ignore such as weight loss, bloating, breast changes, unusual bleeding, skin changes, difficulty swallowing, indigestion, and more. Learn possible clues to finding and detecting cancer early.